Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Read Report Overview - https://www.transparencymarketresearch.com/atrial-fibrillation-market.html Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has been an advancement in diagnoses and treatment of atrial fibrillation. Researchers and experts are also working together to find out new technologies to improve early detection and diagnosis of atrial fibrillation and achieve maximum benefit for atrial fibrillation patients. However, lack of well-trained physicians and the high cost of treatments are hampering the atrial fibrillation market growth. The report has provided a detailed profile of some of the leading players in the global atrial fibrillation market such as Abbott Laboratories, Biosense Webster, Inc., Medtronic Plc, MicroPort Scientific Corporation, Boston Scientific Corporation, Biotronik SE & Co. KG, CardioFocus, Inc., AtriCure Inc., Koninklijke Philips N.V., and Osypka AG. Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1541 Global Atrial Fibrillation Market to Witness Robust Growth during the Forecast Period 2017-2026 According to a study by Transparency Market Research (TMR), the global atrial fibrillation market is expected to witness strong growth. The market is estimated to register 11.0% CAGR during the forecast period 2017-2026. The market is also estimated to reach US$ 10,925.1 million revenue by the end of 2026. On the basis of product type, the EP ablation catheters are expected to emerge as the most preferred product in the global atrial fibrillation market. On the basis of end-user, the market is segmented into electrophysiology labs, hospitals, and ambulatory surgical center. Among these, hospitals are expected to be witness impressive growth during the forecast period 2017-2026. By application, EP ablation is expected to witness the highest growth in the global atrial fibrillation market during the forecast period 2017-2026. Request for Analysis of COVID19 Impact on Atrial Fibrillation Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1541 Geographically, the market is segmented on the basis of North America, Latin America, Europe, Japan, APEJ, and MEA. Europe is expected to dominate the global atrial fibrillation market during the forecast period 2017-2026. A maximum number of catheter ablation are performed in Germany. Rise in the Use of Less Invasive and Advanced Treatment for Atrial Fibrillation
Atrial Fibrillation Market Size will Observe Lucrative Surge by the End 2026
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.